Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Investors complained to the Central Bank about the terms of the exchange of Yandex N. V. shares.

5/20/24 YDEX

Nizhnekamskneftekhim reports for the first quarter

5/20/24 NKNC

Shareholders of Avangard Bank approved dividends for 3 months 2024

5/20/24 AVAN

Shareholders of KuibyshevAzot approved dividends for 2023

5/20/24 KAZT

Yandex is ready to start mass production of delivery robots

5/20/24 YDEX

Cargo turnover at Russian seaports decreased in

5/20/24 NMTP

MTS-Bank's profit increased by more than 30% in the first quarter%

5/17/24 MBNK

Bank Saint Petersburg reports for the first quarter of 2024

5/17/24 BSPB

Shareholders of Rosbank approved dividends for 2023

5/17/24 ROSB

Shareholders of Chelyabinsk Press-Forging Plant approved dividends for 2023

5/17/24 CHKZ